Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
Frontiers | Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
Human CD19 B Cell Flow Cytometry Panel FMC-P-003: R&D Systems
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia | Leukemia
Flow Cytometry of Hematological Malignancies: 9781119611257: Medicine & Health Science Books @ Amazon.com
CD19(high) and CD19(low) subpopulations of B cells. Fresh PBMCs from... | Download Scientific Diagram
CAR.CD19 T-cells generated from Bcp-ALL patients' derived PBMCs... | Download Scientific Diagram
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Frontiers | Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells
CD19 Monoclonal Antibody (HIB19) (14-0199-82)
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor: Molecular Therapy - Oncolytics
PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells: Molecular Therapy
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Overview of CD19-targeted chimeric antigen receptor (CAR)-T-cell... | Download Scientific Diagram
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
CD19 Monoclonal Antibody (6OMP31) (14-0194-82)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Expression of cell surface antigens throughout B-cell maturation. CD19... | Download Scientific Diagram
Human CD19 Alexa Fluor® 750-conjugated Antibody FAB4867S-100UG: R&D Systems
